Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery
ConditionArthropathy of Hip
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGruppo Bioimpianti S.r.l.
About this trial
Post-market clinical follow up investigation on the use of saphir stem and FIN Cup or Dualis system in the treatment of pathologies requiring hip arthroplasty. The main object of the clinical investigation is the evaluation of long term survival rate of Saphir stem.
Eligibility criteria
Qualifiers
patients>18 years
Candidate for primary total hip replacement with femoral stem and acetabular cup
if ostheoarthritis patients aged 18 to 85 years
if femoral neck fracture patients aged 18 to 90 years
Disqualifiers
<18 years
if female, pregnant
patient who has already had primary hip surgery on the same side
local or disseminated neoplastic disease
Trial design
Treatments tested in this trial
- hip arthroplasty with prosthesis
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov